Literature DB >> 2743267

Malignant ascites of unknown origin.

Q S Ringenberg1, D C Doll, T S Loy, J W Yarbro.   

Abstract

To determine the clinical characteristics of patients presenting with malignant ascites, as well as means of evaluating the outcome of patients with the disease, a retrospective review was conducted of all cases of malignant peritoneal effusions diagnosed from 1978 to 1987 at a University Hospital and a Veterans Administration Hospital. Of 65 patients with malignant ascites (40 women; 25 men), the primary site was known in 51 cases (80%). Common sites in women were the ovaries, endometrium, and cervix; in men, common sites were the colon, rectum, and stomach. For five women and nine men the primary site was unknown. Median survival from diagnosis was 7.5 days (mean, 43 days; range 1-256 days). Chest radiograph and abdominal computed tomography (CT) scan did not disclose the occult primary. An occult primary was detected while the patient was alive in only two cases and at autopsy in two other patients. Due to the poor prognosis for this disease, we do not recommend an aggressive approach to malignant ascites of unknown origin, except perhaps in women, in whom ovarian cancer should be suspected.

Entities:  

Mesh:

Year:  1989        PMID: 2743267     DOI: 10.1002/1097-0142(19890801)64:3<753::aid-cncr2820640330>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Massive ascites of unknown origin.

Authors:  Shi-Min Yuan
Journal:  Int J Clin Exp Med       Date:  2014-02-15

2.  How valuable is ascitic cytology in the detection and management of malignancy?

Authors:  R O S Karoo; T D R Lloyd; G Garcea; H D Redway; G S R Robertson
Journal:  Postgrad Med J       Date:  2003-05       Impact factor: 2.401

3.  Development and validation of the self-completed ascites impact measure to understand patient motivation for requesting a paracentesis.

Authors:  Bruce Crawford; Elizabeth Piault; Walter Gotlieb; Florence Joulain
Journal:  Patient Relat Outcome Meas       Date:  2012-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.